AE Wealth Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$264K Buy
37,935
+1,352
+4% +$7.53K ﹤0.01% 1549
2026
Q1
$143K Buy
36,583
+4,837
+15% +$21.5K ﹤0.01% 1690
2025
Q4
$144K Buy
31,746
+4,786
+18% +$24.6K ﹤0.01% 1596
2025
Q3
$165K Buy
26,960
+7,367
+38% +$46.6K ﹤0.01% 1442
2025
Q2
$127K Sell
19,593
-23
-0.1% -$124 ﹤0.01% 1421
2025
Q1
$104K Buy
19,616
+6,973
+55% +$47.6K ﹤0.01% 1434
2024
Q4
$106K Buy
+12,643
New +$97.6K ﹤0.01% 1410
2023
Q1
Sell
-49,854
Closed -$976K 1999
2022
Q4
$976K Buy
49,854
+3,706
+8% +$75.1K 0.01% 990
2022
Q3
$881K Buy
+46,148
New +$934K 0.01% 991

Other funds holding TBI

AE Wealth Management's TBI Position: Q2 2026 in Review

AE Wealth Management increased its Trueblue (TBI) stake by 3.7% in Q2 2026, buying an estimated $7.53K and bringing the position to 37,935 shares worth $264K. The position accounts for ﹤0.01% of the portfolio, ranked #1549.

AE Wealth Management first reported a position in TBI in Q3 2022 and has held it in 9 quarters since. The position peaked at $976K in Q4 2022. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • AE Wealth Management held 37,935 shares of Trueblue worth $264K as of Q2 2026.
  • AE Wealth Management bought 1,352 Trueblue shares in Q2 2026, an estimated $7.53K.
  • Trueblue made up ﹤0.01% of AE Wealth Management's portfolio in Q2 2026, its #1549 holding.
  • AE Wealth Management first reported a position in Trueblue in Q3 2022 and has held it in 9 quarters since.
  • AE Wealth Management's Trueblue position peaked at $976K in Q4 2022.
  • 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.